Scarica l'app Stockscreener
0.3926
16.49%
-0.0775
Dopo l'orario di chiusura:
.41
0.0174
+4.43%
Renovaro Inc Borsa (RENB) Ultime notizie
Health Care Stocks Tumble On Multiple Fronts - Finimize
Renovaro Says Predictive Oncology Terminates Merger Transaction With Co - MarketScreener
RENB stock touches 52-week low at $0.4 amid sharp annual decline - Investing.com Australia
Renovaro BioSciences (RENB) Challenges Merger Termination - GuruFocus
Renovaro Biosciences Announces Breach Of Agreement By Predictive Oncology, Legal Action Pending - Nasdaq
Renovaro Says Predictive Oncology Terminates Merger Deal; Shares Fall - MarketScreener
Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewswire
Merger Crisis: Renovaro Threatens Legal Action After Predictive Oncology Backs Out - Stock Titan
Charles Schwab Investment Management Inc. Buys 163,160 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
Bank of New York Mellon Corp Grows Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Recession Risk: Is It Going to Happen? Here Are the Key Clues - The Globe and Mail
5 Quality Companies Trading Near Their Lowest Valuations Ever - The Globe and Mail
McCormick (MKC) Q1 Earnings: What To Expect - The Globe and Mail
PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs - openPR
Rhumbline Advisers Acquires 62,204 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World
New York State Common Retirement Fund Trims Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Ratio Chart Of U.S. Dollar Index Against 10Y U.S. Notes Is Pointing Much Lower - The Globe and Mail
Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Yahoo Finance
Sea (SE) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals
MarketsMedicine Hat News - Financial Content
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail
What To Expect From Best Buy’s (BBY) Q4 Earnings - The Globe and Mail
Milestone Merger Payment made with Predictive Oncology - openPR
Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire
Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times
Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq
Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan
Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan
Renovaro Stock Price, Quotes and Forecasts | NASDAQ:RENB - Benzinga
Renovaro Biosciences Announces Merger with BioSymetrics - TipRanks
Rocket Lab Stock Is Down 30% in the Last Month. Should You Buy the Dip or Run Far Away? - The Globe and Mail
Renovaro announces $15 million in equity - MSN
Renovaro Inc. (RENB) Merges with BioSymetrics to Advance AI-Driven Cancer Research - Insider Monkey
Renovaro Announces $15 million in Equity Committed - GlobeNewswire
Renovaro secures $15 million for cancer AI technology By Investing.com - Investing.com Australia
Enochian Biosciences Stock: AI-Powered Merger Fuels Growth - sharewise
Sector Update: Health Care -February 26, 2025 at 03:37 pm EST - Marketscreener.com
Merger Agreement with BioSymetrics to Accelerate Biomarker Identification, Enhance Drug Discovery and Expand Precision Medicine Applications in Advanced Cancer Diagnosis and Treatment | FinancialContent Business Page - Financial Content
Renovaro and BioSymetrics merge to boost AI-driven drug discovery - Investing.com
Renovaro and BioSymetrics merge to boost AI-driven drug discovery By Investing.com - Investing.com South Africa
$15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB - WICZ
Renovaro Agrees to Merge With BioSymetrics -February 26, 2025 at 01:47 pm EST - Marketscreener.com
Renovaro & Biosymetrics Announce Definitive Merger Agreement -February 26, 2025 at 01:27 pm EST - Marketscreener.com
Renovaro and BioSymetrics Announce Definitive Merger - GlobeNewswire
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and - EIN News
Renovaro Gets $15 Million in Equity Committed; Shares Rise -February 26, 2025 at 10:58 am EST - Marketscreener.com
Renovaro secures $15 million for cancer AI technology - Investing.com
10.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):